Rentokil Initial (RTO) Stock Price, News & Analysis

Company Overview

Rentokil Initial plc is a business services company specializing in pest control, hygiene, and related workplace services. Through brands including Rentokil, Terminix, Initial, and Ambius, it provides commercial and residential pest management, washroom hygiene, restroom services, interior landscaping, and other solutions designed to support healthier, safer, and more productive environments.

The company serves customers across a broad range of industries, including healthcare, hospitality, food service, manufacturing, retail, and property management. Its services include the prevention and treatment of insects and rodents, sanitation and hygiene programs, restroom supplies and maintenance, air and surface hygiene, and plant care for commercial interiors.

Rentokil Initial traces its history to Rentokil, founded in the United Kingdom in 1925, and Initial, a hygiene and workwear services business with earlier roots. The two companies combined in 1996. Rentokil Initial is headquartered in Crawley, England, and operates across North America, Europe, Asia-Pacific, and other international markets. Its acquisition of Terminix in 2022 expanded its presence in North American pest control and added a major residential and commercial service platform.

Key Stats

• Today's Range: $19.83 to $20.07
• 50-Day Range: $19.77 to $29.45
• 52-Week Range: $19.50 to $34.67
• Volume: 2.24 million shs
• Average Volume: 2.09 million shs
• Market Capitalization: $10.08 billion
• P/E Ratio: N/A
• Dividend Yield: 1.80%
• Price Target: $31.90
• Consensus Rating: Moderate Buy

Rentokil Initial Stock Analysis - MarketRank™

Rentokil Initial scored higher than 70% of companies evaluated by MarketBeat, and ranked 315th out of 653 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Rentokil Initial has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 1 strong buy rating, 7 buy ratings, 5 hold ratings, and 1 sell rating.

Upside Potential

Rentokil Initial has a consensus price target of $31.90, representing about 59.9% upside from its current price of $19.96.

Amount of Analyst Coverage

Rentokil Initial has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.43%

Earnings Growth

Earnings for Rentokil Initial are expected to grow by 9.43% in the coming year, from $1.06 to $1.16 per share.

Price to Earnings Growth Ratio

Rentokil Initial has a PEG Ratio of 1.97. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Rentokil Initial has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.65% of the float of Rentokil Initial has been sold short.

Short Interest Ratio / Days to Cover

Rentokil Initial has a short interest ratio ("days to cover") of 2.17, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Rentokil Initial has recently increased by 26.56%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Rentokil Initial pays a meaningful dividend of 1.80%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Rentokil Initial does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Rentokil Initial will have a dividend payout ratio of 31.03% next year. This indicates that Rentokil Initial will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.8 / 5
• News Sentiment: -0.72

News Sentiment

Rentokil Initial has a news sentiment score of -0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Industrials companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Rentokil Initial this week, compared to 1 article on an average week.

MarketBeat Follows

Only 1 people have added Rentokil Initial to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rentokil Initial insiders have not sold or bought any company stock.

Percentage Held by Institutions

9.91% of the stock of Rentokil Initial is held by institutions.

Company Calendar

• Last Earnings: 8/06/2020
• Record date for 9/22 Dividend: 8/14/2026
• Ex-Dividend for 9/22 Dividend: 8/14/2026
• Dividend Payable: 9/22/2026
• Today: 10/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Industrials
• Industry: Commercial Services & Supplies
• Sub-Industry: Environmental & Facilities Services
• Current Symbol: NYSE:RTO
• CIK: 930157
• Web: www.rentokil-initial.com
• Phone: 441293858000
• Fax: N/A
• Employees: 63,388
• Year Founded: 1925

Price Target and Rating

• Average Price Target for Rentokil Initial: $31.90
• High Price Target: $35.00
• Low Price Target: $26.70
• Potential Upside/Downside: +59.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 18.83
• P/E Growth: 1.97
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $6.91 billion
• Price / Sales: 1.46
• Cash Flow: $2.34 per share
• Price / Cash Flow: 8.54
• Book Value: $10.88 per share
• Price / Book: 1.83

Miscellaneous

• Outstanding Shares: 505,210,000
• Free Float: N/A
• Market Cap: $10.08 billion
• Optionable: Not Optionable
• Beta: 1.01